Nasdaq: MBX
MBX Biosciences insiders
The officers, directors and 10% owners of MBX Biosciences, Inc. who hold the most stock, valued at the live MBX price.
$53.41
MBX today −$10K (−0.02%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 7
- Their MBX stock
- $609M
- Market value
- $2.65B
- Held by ranked insiders
- 23.0%
Insiders by value of MBX holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Fhmls X, L.P. | 10% owner | 4,552,774 | $243M | 9.17% | Corporate |
| 2 | NEA Partners 17, L.P. | 10% owner | 3,614,486 | $193M | 7.28% | Corporate |
| 3 | Wellington Biomedical Innovation Master Investors (Cayman) II L.P. | 10% owner | 1,790,122 | $95.6M | 3.61% | Corporate |
| 4 | P. Kent Hawryluk | President & CEO | 1,214,444 | $64.9M | 2.45% | 2115th |
| 5 | James M. Cornelius | Director | 102,082 | $5.5M | 0.21% | 13634th |
| 6 | Steven L. Hoerter | Chairman, President and CEO | 98,045 | $5.2M | 0.20% | 14008th |
| 7 | John W. Smither | Chief Financial Officer | 28,000 | $1.5M | <0.1% | 12738th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for MBX Biosciences; see each profile for the filing.